Types of Photoplethysmographic Waves in Adult Patients with Septic Shock (SHOCK PLETH)

January 15, 2025 updated by: Juan Fernando Bautista Garcia, Hospital General de México Dr. Eduardo Liceaga
The objective of this study is to identify the types of Photoplethysmographic waves present in adults with septic shock and determine whether these waves correlate with other variables of tissue hypoperfusion such as capillary refil, serum lactate and mottling score.

Study Overview

Status

Recruiting

Detailed Description

Photoplethysmography is the technology used in pulse oximeters in order to calculate arterial oxygen saturation and pulse rate, this technology generates a wave whose morphology has been related to blood flow and arterial tone. Recently Tusman and collaborators described a morphological classification of the photoplethysmografic wave that has a high correlation with arterial tone, such classification is divided in 6 types; Types I and II indicate vasoconstriction, Type III normal arterial tone and Types IV, V and VI describe mild, medium and severe vasodilation respectively, therefore it could be used to identify the arterial tone in those patients with septic shock. This study will identify the type of photoplethysmographic waves that are present in adults with septic shock based in the Tusman and collaborators classification, it will also describe the frequency of appearance and their correlation with other hemodynamic variables such as capillary refill, serum lactate, mottling score, heart rate, mean arterial pressure, pulse pressure and perfusion index.

Study Type

Observational

Enrollment (Estimated)

116

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Cuauhtemoc
      • Mexico city, Cuauhtemoc, Mexico, 06726
        • Recruiting
        • Hospital General de México Dr. Eduardo Liceaga
        • Contact:
          • Hospital General de México Dr. Eduardo Liceaga Hospital General de México Dr. Eduardo Liceaga, Hospital
          • Phone Number: 1316 5527892000
          • Email: direccionhgmliceaga@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All adult patients admitted to the emergency department at "Hospital General de México Dr. Eduardo Liceaga" and meet the criteria for septic shock established in Sepsis 3.0 and have signed the informed consentment will be included in the study.

Description

Inclusion Criteria:

  • Adult patients of 18 years of age and above dignossed with septic shock according to the definition stated in Sepsis 3.0
  • Patients with axillary temperature above 36°C
  • Patients and/or family that agree to participate in such study and sign the informed consentment
  • Patients that tolerate supine position

Exclusion Criteria:

  • Patients with Cardiogenic shock, hipovolemic, obstructive and distributive (neurogenic, anafilactic) shock the exception being septic shock
  • Patients with history of any type of cardiac arrhythmia
  • Patients with history of chronic hepatic disease
  • Patients with limited or diffuse systemic sclerosis
  • Patients that have scarring, nail polish or thickened nails that may impede the proper placement and accurate measurement of photoplethysmography with the pulse oximeter
  • Patients with history of heart insufficiency P- atients with septic shock that already have vasopressor aggents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Photoplethysmography wave types in adult patiens with septic shock
Time Frame: After the inclusion of the patient.
The type of Photoplethysmography wave obtained and digitized through the sensor of a conventional pulse oximeter without autoscale. The wave will be classified in type I, II, III, IV, V and VI according to the criteria proposed by Tusman and collaborators
After the inclusion of the patient.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Capillary refill
Time Frame: After the inclusion of the patient
Mesurement of the time it takes for the ventral surface of the fingers to return to its normal color after being compressed by a transparent microscope slide for 10 seconds. Measured in seconds.
After the inclusion of the patient
Mottling score
Time Frame: After the inclusion of the patient
Classification regarding the type of mottling surrounding the knee in each patient. The classification is as folllows 0= no mottling, 1= Mottling the size of a coin on the knee, 2= mottling extending just over the superior part of the knee, 3= Mottling covering up to half the thigh, 4= mottling continues to the inguinal fold, 5= severe mottling extending beyond the inguinal area.
After the inclusion of the patient
Serum lactate levels
Time Frame: After the inclusion of the patient
Mesurement of serum lactate through venous blood gass analysis at hospital admittanace. Mesured in mmol/L
After the inclusion of the patient
Heart rate
Time Frame: After the inclusion of the patient
Determination of the number of heart beats per minute in patients obtenined with telemetry. Messured in beats per minute
After the inclusion of the patient
Sistolic and diastolic blood pressure
Time Frame: After the inclusion of the patient
Messurement of arterial blood pressure with an adult sized aneroid sphygmomanometer. Messurement in mmHg.
After the inclusion of the patient
Perfussion index
Time Frame: After the inclusion of the patien
Messurement of the perfusion index obtained and calculated by a sensor in a conventional pulse oximeter without autoscale. Measurement in whole numbers.
After the inclusion of the patien

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juan Fernando Bautista Garcia, MD, Hospital General de México Dr. Eduardo Liceaga

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2024

Primary Completion (Estimated)

May 1, 2025

Study Completion (Estimated)

May 30, 2025

Study Registration Dates

First Submitted

January 15, 2025

First Submitted That Met QC Criteria

January 15, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 15, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Photoplethysmography

Subscribe